Eton Pharmaceuticals posts 99% revenue growth, raises 2026 guidance to over $145 millionAug 13Quarterly updateEton Pharmaceuticals, Inc.
Eton licenses ASN-001 topical gel to expand infantile hemangioma portfolioAug 5M&AEton Pharmaceuticals, Inc.
Eton Pharmaceuticals names Danka Radosavljevic as Chief Operating OfficerAug 4PeopleEton Pharmaceuticals, Inc.
Eton Pharmaceuticals submits FDA supplement to expand KHINDIVI to younger childrenJul 29Regulatory decisionEton Pharmaceuticals, Inc.hydrocortisone
Sign in